{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T19:14:36Z","timestamp":1784402076062,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,18]]},"DOI":"10.7759\/cureus.77615","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:49:38Z","timestamp":1737200978000},"source":"Crossref","is-referenced-by-count":2,"title":["Eosinophilic Fasciitis: A Case Series"],"prefix":"10.7759","author":[{"given":"Elisa","family":"Macedo Br\u00e1s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio-Pedro","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Ferreira da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031982","article-title":"Eosinophilic fasciitis: current and remaining challenges","volume":"24","author":"Mazilu D","year":"2023","unstructured":"Mazilu D, Bolta\u0219iu T\u0103taru LA, Mardale DA, et al.. Eosinophilic fasciitis: current and remaining challenges. Int J Mol Sci. 2023, 24:10.3390\/ijms24031982","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.05.030","article-title":"Drug-induced eosinophilic fasciitis: a dual pharmacovigilance analysis","volume":"86","author":"Teboul A","year":"2022","unstructured":"Teboul A, Chouchana L, Durrieu G, Eftekhari P, Treluyer JM, Mouthon L, Chaigne B. Drug-induced eosinophilic fasciitis: a dual pharmacovigilance analysis. J Am Acad Dermatol. 2022, 86:1372-5. 10.1016\/j.jaad.2021.05.030","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2024.03.006","article-title":"Eosinophilic fasciitis: from pathophysiology to therapeutics (Article in French)","volume":"45","author":"Knapp S","year":"2024","unstructured":"Knapp S, Bolko L, Servettaz A, Didier K. Eosinophilic fasciitis: from pathophysiology to therapeutics (Article in French). Rev Med Interne. 2024, 45:488-97. 10.1016\/j.revmed.2024.03.006","journal-title":"Rev Med Interne"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60526-2","article-title":"Groove sign in eosinophilic fasciitis","volume":"384","author":"Pinal-Fernandez I","year":"2014","unstructured":"Pinal-Fernandez I, Callejas-Moraga EL, Roade-Tato ML, Simeon-Aznar CP. Groove sign in eosinophilic fasciitis. Lancet. 2014, 384:1774. 10.1016\/S0140-6736(14)60526-2","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8485-8","article-title":"Eosinophilic skin diseases: a comprehensive review","volume":"50","author":"Long H","year":"2016","unstructured":"Long H, Zhang G, Wang L, Lu Q. Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol. 2016, 50:189-213. 10.1007\/s12016-015-8485-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14160","article-title":"Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis","volume":"45","author":"Jinnin M","year":"2018","unstructured":"Jinnin M, Yamamoto T, Asano Y, et al.. Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis. J Dermatol. 2018, 45:881-90. 10.1111\/1346-8138.14160","journal-title":"J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.019","article-title":"Diagnosis and classification of eosinophilic fasciitis","volume":"13","author":"Pinal-Fernandez I","year":"2014","unstructured":"Pinal-Fernandez I, Selva-O' Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev. 2014, 13:379-82. 10.1016\/j.autrev.2014.01.019","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2012.08.001","article-title":"Eosinophilic fasciitis (Shulman disease)","volume":"26","author":"Lebeaux D","year":"2012","unstructured":"Lebeaux D, S\u00e8ne D. Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol. 2012, 26:449-58. 10.1016\/j.berh.2012.08.001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.3648","article-title":"Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers","volume":"152","author":"Wright NA","year":"2016","unstructured":"Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA. Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers. JAMA Dermatol. 2016, 152:97-9. 10.1001\/jamadermatol.2015.3648","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.0120","article-title":"Mycophenolate mofetil for eosinophilic fasciitis: a retrospective analysis from 3 tertiary care centers","volume":"156","author":"Tkachenko E","year":"2020","unstructured":"Tkachenko E, Steuer AB, Lo K, LaChance A, Merola JF, Femia AN, Vleugels RA. Mycophenolate mofetil for eosinophilic fasciitis: a retrospective analysis from 3 tertiary care centers. JAMA Dermatol. 2020, 156:595-7. 10.1001\/jamadermatol.2020.0120","journal-title":"JAMA Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13770","article-title":"Baseline characteristics and long-term outcomes of eosinophilic fasciitis in 89 patients seen at a single center over 20\u00a0years","volume":"23","author":"Mango RL","year":"2020","unstructured":"Mango RL, Bugdayli K, Crowson CS, et al.. Baseline characteristics and long-term outcomes of eosinophilic fasciitis in 89 patients seen at a single center over 20\u00a0years. Int J Rheum Dis. 2020, 23:233-9. 10.1111\/1756-185X.13770","journal-title":"Int J Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04887-3","article-title":"Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review","volume":"41","author":"Kougkas N","year":"2021","unstructured":"Kougkas N, Bertsias G, Papalopoulos I, Repa A, Sidiropoulos P, Avgoustidis N. Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review. Rheumatol Int. 2021, 41:1833-7. 10.1007\/s00296-021-04887-3","journal-title":"Rheumatol Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12890\/2020_001485","article-title":"Effectiveness of tocilizumab in the treatment of fasciitis with eosinophilia: two case reports","volume":"7","author":"Pinheiro G","year":"2020","unstructured":"Pinheiro G, Costa AR, Campar A, Mendon\u00e7a T. Effectiveness of tocilizumab in the treatment of fasciitis with eosinophilia: two case reports. Eur J Case Rep Intern Med. 2020, 7:001485. 10.12890\/2020_001485","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.8017","article-title":"Functional and cutaneous treatment outcomes with intravenous immunoglobulin for eosinophilic fasciitis: a retrospective study","volume":"23","author":"Obiakor B","year":"2024","unstructured":"Obiakor B, Fan W, Jacobson R, Gandelman J, Haemel A. Functional and cutaneous treatment outcomes with intravenous immunoglobulin for eosinophilic fasciitis: a retrospective study. J Drugs Dermatol. 2024, 23:e107-9. 10.36849\/JDD.8017","journal-title":"J Drugs Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-199808000-00017","article-title":"Therapeutic fasciectomy for eosinophilic fasciitis","volume":"41","author":"Neumeister MW","year":"1998","unstructured":"Neumeister MW, Robertson GA. Therapeutic fasciectomy for eosinophilic fasciitis. Ann Plast Surg. 1998, 41:208-10. 10.1097\/00000637-199808000-00017","journal-title":"Ann Plast Surg"},{"key":"ref16","article-title":"Diffuse fasciitis with eosinophilia: a new syndrome?","volume":"88","author":"Shulman LE","year":"1975","unstructured":"Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome?. Trans Assoc Am Physicians. 1975, 88:70-86.","journal-title":"Trans Assoc Am Physicians"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16535","article-title":"Population-based prevalence of eosinophilic fasciitis (Shulman syndrome): a capture-recapture study","volume":"179","author":"Spielmann L","year":"2018","unstructured":"Spielmann L, Arnaud L, Severac F, et al.. Population-based prevalence of eosinophilic fasciitis (Shulman syndrome): a capture-recapture study. Br J Dermatol. 2018, 179:516-7. 10.1111\/bjd.16535","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15561","article-title":"Characteristics of Japanese patients with eosinophilic fasciitis: a brief multicenter study","volume":"47","author":"Yamamoto T","year":"2020","unstructured":"Yamamoto T, Ito T, Asano Y, et al.. Characteristics of Japanese patients with eosinophilic fasciitis: a brief multicenter study. J Dermatol. 2020, 47:1391-4. 10.1111\/1346-8138.15561","journal-title":"J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.11.009","article-title":"Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): a multicenter retrospective study of 119 patients","volume":"88","author":"Zuelgaray E","year":"2023","unstructured":"Zuelgaray E, Chevret S, Jachiet M, et al.. Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): a multicenter retrospective study of 119 patients. J Am Acad Dermatol. 2023, 88:160-3. 10.1016\/j.jaad.2020.11.009","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185572-eosinophilic-fasciitis-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:49:40Z","timestamp":1737200980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185572-eosinophilic-fasciitis-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.77615","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,18]]}}}